Gabriel Cohn - Net Worth and Insider Trading

Gabriel Cohn Net Worth

The estimated net worth of Gabriel Cohn is at least $136 dollars as of 2024-11-10. Gabriel Cohn is the Chief Medical Officer of Homology Medicines Inc and owns about 146 shares of Homology Medicines Inc (FIXX) stock worth over $136. Details can be seen in Gabriel Cohn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gabriel Cohn has not made any transactions after 2022-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gabriel Cohn

To

Gabriel Cohn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gabriel Cohn owns 1 companies in total, including Homology Medicines Inc (FIXX) .

Click here to see the complete history of Gabriel Cohn’s form 4 insider trades.

Insider Ownership Summary of Gabriel Cohn

Ticker Comapny Transaction Date Type of Owner
FIXX Homology Medicines Inc 2022-01-05 Chief Medical Officer

Gabriel Cohn Latest Holdings Summary

Gabriel Cohn currently owns a total of 1 stock. Gabriel Cohn owns 146 shares of Homology Medicines Inc (FIXX) as of January 5, 2022, with a value of $136.

Latest Holdings of Gabriel Cohn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FIXX Homology Medicines Inc 2022-01-05 146 0.93 136

Holding Weightings of Gabriel Cohn


Gabriel Cohn Form 4 Trading Tracker

According to the SEC Form 4 filings, Gabriel Cohn has made a total of 1 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Homology Medicines Inc is the sale of 92 shares on January 5, 2022, which brought Gabriel Cohn around $6,279.

Insider Trading History of Gabriel Cohn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gabriel Cohn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gabriel Cohn Ownership Network

Ownership Network List of Gabriel Cohn

No Data

Ownership Network Relation of Gabriel Cohn

Insider Network Chart

Gabriel Cohn Owned Company Details

What does Homology Medicines Inc do?

Who are the key executives at Homology Medicines Inc?

Gabriel Cohn is the Chief Medical Officer of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .

Homology Medicines Inc (FIXX) Insider Trades Summary

Over the past 18 months, Gabriel Cohn made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Homology Medicines Inc Insider Transactions

No Available Data

Gabriel Cohn Mailing Address

Above is the net worth, insider trading, and ownership report for Gabriel Cohn. You might contact Gabriel Cohn via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.